Apollomics Regains Nasdaq Compliance, Delisting Threat Lifted
APLM has more than doubled off its 52-week low of $3.659 on light trading volume (0.3× avg).
Summary
Apollomics has resolved the Nasdaq delisting threat that emerged in June. The company received notice on July 8 that it now meets the Market Value of Listed Securities requirement, with its market value holding at or above $35 million for the required 10 consecutive business days. This follows the June 24 disclosure of the initial deficiency notice and the termination of a key licensing deal. The compliance closure removes immediate exchange risk, though the company's going-concern warning from April remains a fundamental concern.
At the time of this announcement, APLM was trading at $18.95 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $41.6M. The 52-week trading range was $3.66 to $42.12. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.